Session No.59 Immunotherapy and Biotherapy, co-chairs: Zhigang Tian and Eric Vivier, October 29th, 8:30 - 12:00
Oct 29, 9:00 - 9:30:
Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells, Eric Vivier
Visit the World Life Science Conference website
Date